Larvol Delta - reaINAVO-A-Study-to-Evaluate-the-Effectiveness-and-Safety-of-Inavolisib-in-Participants-With-Endocrineresistant-PIK3CAmutated-Hormone-Receptorpositive-HER2negative-Locally-Advanced-or-Metastatic-Breast-Cancer

Itovebi (inavolisib) - Roche

Ibrance (palbociclib) - Pfizer

fulvestrant - Generic mfg.

http://clinicaltrials.gov/ct2/show/NCT07347600

Sep 9, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next